PHARMACYTE BIOTECH, INC. Depreciation
PHARMACYTE BIOTECH, INC. (PMCB) reported Depreciation of $0 for the 12-month period ending 2013-04-30, per its 10-K filed 2013-07-29.
Discontinued › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2013-07-29
- PHARMACYTE BIOTECH, INC. depreciation for the quarter ending 2013-04-30 was $0.00.
- PHARMACYTE BIOTECH, INC. depreciation for the quarter ending 2013-01-31 was $0.00.
- PHARMACYTE BIOTECH, INC. depreciation for the quarter ending 2012-10-31 was $0.00.
- PHARMACYTE BIOTECH, INC. depreciation for the quarter ending 2012-07-31 was $0.00.
- PHARMACYTE BIOTECH, INC. depreciation for fiscal 2013 was $0.00, a 100.00% decline from fiscal 2012.
- PHARMACYTE BIOTECH, INC. depreciation for fiscal 2012 was $24.66K.
| Period end | Depreciation 3 month | Depreciation 6 month | Depreciation 9 month | Depreciation 12 month |
|---|---|---|---|---|
| 2013-04-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-07-29 | $0.00 derived: sum of 2 quarters · filed 2013-07-29 | $0.00 derived: sum of 3 quarters · filed 2013-07-29 | $0.00 10-K · filed 2013-07-29 |
| 2013-01-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-03-26 | $0.00 derived: sum of 2 quarters · filed 2013-03-26 | $0.00 10-Q · filed 2013-03-26 | |
| 2012-10-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2012-12-26 | $0.00 10-Q · filed 2012-12-26 | ||
| 2012-07-31 | $0.00 10-Q · filed 2012-09-19 | |||
| 2012-04-30 | $24.66K 10-K · filed 2013-07-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |